Work

Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer

Year: 2023

Type: article

Study design: Observational Study

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2023.03.001

Authors: Oyomoare L. Osazuwa-Peters, Lauren E. Wilson, Devon K. Check, Megan C. Roberts, Swetha Srinivasan, Amy G. Clark, Jeffrey Crawford, Elizabeth Chrischilles, Ryan M. Carnahan, W. Scott Campbell, Lindsay G. Cowell, Robert Greenlee, Andrea M. Abbott, Abu S.M. Mosa, Vasanthi Mandhadi, Alexander Stoddard, Michaela A. Dinan

Institutions: Duke University, Duke Medical Center, University of North Carolina at Chapel Hill, University of Iowa, University of Nebraska Medical Center, The University of Texas Southwestern Medical Center, Marshfield Clinic Research Foundation, Marshfield Clinic Research Institute, Medical University of South Carolina, University of Missouri, Medical College of Wisconsin, Yale University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: University of Texas Southwestern Medical Center, University of Iowa, Vanderbilt University Medical Center, School of Medicine, Indiana University

OpenAlex ID: W4327922508

FWCI: 0.482

Cites: 24

Cited by: 3

Related to: 10